Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

OCS-PRECISE: Detecting and Predicting Post-stroke Cognitive Impairment

NCT07897916 is registered in ClinicalTrials.gov with University of Copenhagen as lead sponsor.

NCT NCT07897916 Not yet recruiting Observational 180 participants (estimated) Started 2026 2 sites

Follow this trial by email Email me the PDF

Get the NCT07897916 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Summary

Not yet recruiting, started November 2026. Observational study, 180 participants (estimated). Lead sponsor University of Copenhagen; Denmark. Primary measure: Diagnostic accuracy of the OCS: the ability of the OCS to identify cognitive impairments in the subacute... 41 linked papers (newest 2024).

How it compares

71 similar trials: same condition (Hemorrhagic Stroke) and phase

Enrollment

This trial
180
Middle half
100 to 1,000
Median
331
Trials with a value
70

Months from start to completion

This trial
19
Middle half
15.3 to 76.5
Median
27.5
Trials with a value
71

Sites

This trial
2
Middle half
1 to 2
Median
1
Trials with a value
64
Posted results or a linked paper 32% 23 of 71 similar trials; this trial: yes

Registry record

As filed in ClinicalTrials.gov.

Title
OCS-PRECISE: Detecting and Predicting Post-stroke Cognitive Impairment
Lead sponsor
University of Copenhagen
Phase
Observational
Overall status
Not yet recruiting
Start date
November 30, 2026
Completion date
June 30, 2028
Enrollment
180 (estimated)
Sites
2

Conditions

MeSH condition names; the registry's own terms follow.

Aphasia, Cognitive Dysfunction, Fatigue, Hemorrhagic Stroke, Ischemic Stroke, Stroke

Registry terms: hemorrhagic stroke, intracerebral, post-stroke cognitive impairment (psci)

Who could take part, where it ran, who ran it

As filed in ClinicalTrials.gov.

Sex
All
Minimum age
18 Years
Healthy volunteers
No
Study type
Observational
Sites
2
Countries
Denmark
Lead sponsor
University of Copenhagen

Arms

As registered; 1 arm.

Registered arms
Arm Type Interventions
OCS-Precise stroke survivors

Primary endpoints

Registered primary outcome measures; 1 primary.

Registered primary endpoints
Measure Time frame
Diagnostic accuracy of the OCS: the ability of the OCS to identify cognitive impairments in the subacute and chronic stage after stroke From enrolment in the subacute stage (max three weeks post-stroke) to assessment in the chronic stage (6-9 months post-stroke).
Show registry wording

Diagnostic accuracy will be evaluated in both the subacute and the chronic stage. First, agreement between impairment classifications using the OCS and impairment classifications on matched comprehensive neuropsychological tests will be quantified using Cohen's kappa coefficients. Second, diagnostic accuracy will be assessed by estimating sensitivity and specificity of OCS in relation to the matched comprehensive neuropsychological test battery.

Impairment on a test is determined using cut-offs provided in test manuals when available or using norm-based cut-offs set at 1,5 standard deviations bellow the mean (or equivalent).

Papers

PubMed papers this trial cites; 41 papers, results papers first, then newest first.

+36 more papers

Source: PubMed, NCBI/NLM (public domain).

Lead sponsor's other trials

University of Copenhagen, most recent start first.

Similar trials

Same condition (Hemorrhagic Stroke) and phase, most recent start first.